Stable Istotope Labelled Duvortuxizumab Biosimilar – Anti-CD19/CD3E mAb – Research Grade

Reference: PX-TA1432-SIL-1MG
Product nameStable Istotope Labelled Duvortuxizumab Biosimilar - Anti-CD19/CD3E mAb - Research Grade
SourceCAS 1831098-91-9
SpeciesChimeric,Humanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsJNJ-64052781,MGD011,RES192M1.2
ReferencePX-TA1432-SIL
Related ProductsPX-P4004
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypescFv -h-CH2-CH3(_scFv)_h-CH2-CH3
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-CD19/CD3E[Homo sapiens] (Duvortuxizumab) Monoclonal Antibody

Duvortuxizumab is investigated for the treatment of Lymphoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Duvortuxizumab Biosimilar – Anti-CD19/CD3E mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.